Unfolded protein response induced by Brefeldin A increases collagen type I levels in hepatic stellate cells through an IRE1α, p38 MAPK and Smad-dependent pathway

Biochim Biophys Acta. 2016 Aug;1863(8):2115-23. doi: 10.1016/j.bbamcr.2016.05.002. Epub 2016 May 4.

Abstract

Unfolded protein response (UPR) triggered as a consequence of ER stress has been shown to be involved in the development of different pathologies, including fibrotic disorders. In the present paper we explore the role played by UPR on a key fibrogenic parameter in the liver: collagen type I levels in activated hepatic stellate cells (HSC). Using Brefeldin A (BFA) as an ER stress inducer we found that UPR correlated with enhanced mRNA and protein levels of collagen type I in a cell line of immortalized non-tumoral rat HSC. Analysis of the three branches of UPR revealed the activation of IRE1α, PERK and ATF6 in response to BFA, although PERK activation was shown not to be involved in the fibrogenic action of BFA. BFA also activated p38 MAPK in an IRE1α-dependent way and the p38 MAPK inhibitor SB203580 prevented the increase in collagen type I mRNA and protein levels caused by BFA, suggesting the involvement of this kinase on this effect. Analysis of Smad activation showed that phosphorylated nuclear levels of Smad2 and 3 were increased in response to BFA treatment. Inhibition of Smad3 phosphorylation by SIS3 prevented the enhancement of collagen type I levels caused by BFA. Pretreatment with IRE1α and p38 MAPK inhibitors also prevented the increased p-Smad3 accumulation in the nucleus, suggesting an IRE1α-p38 MAPK-Smad pathway to be responsible for the fibrogenic action of BFA on HSC.

Keywords: Collagen type I; Hepatic stellate cells; Unfolded protein response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brefeldin A / pharmacology*
  • Cell Line
  • Collagen Type I / biosynthesis*
  • Collagen Type I / genetics
  • Endoplasmic Reticulum Stress / drug effects*
  • Endoplasmic Reticulum Stress / physiology
  • Endoribonucleases / antagonists & inhibitors
  • Endoribonucleases / physiology*
  • Fibrosis
  • Gene Expression Regulation / drug effects
  • Hepatic Stellate Cells / drug effects*
  • Hepatic Stellate Cells / metabolism
  • Imidazoles / pharmacology
  • MAP Kinase Signaling System / drug effects*
  • Multienzyme Complexes / antagonists & inhibitors
  • Multienzyme Complexes / physiology*
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Protein Serine-Threonine Kinases / antagonists & inhibitors
  • Protein Serine-Threonine Kinases / physiology*
  • Pyridines / pharmacology
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • Rats
  • Smad3 Protein / physiology*
  • Unfolded Protein Response / drug effects*
  • Unfolded Protein Response / physiology
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / physiology*

Substances

  • Collagen Type I
  • Ern1 protein, rat
  • Imidazoles
  • Multienzyme Complexes
  • Pyridines
  • RNA, Messenger
  • Smad3 Protein
  • Smad3 protein, rat
  • Brefeldin A
  • Protein Serine-Threonine Kinases
  • p38 Mitogen-Activated Protein Kinases
  • Endoribonucleases
  • SB 203580